Predictive Signature of Benralizumab Response

Conditions:   Asthma; Eosinophilic;   Severe Asthma Intervention:   Drug: Benralizumab Prefilled Syringe Sponsors:   Nantes University Hospital;   AstraZeneca;   Ministère de la Santé - France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials